What is Dr. Zubair Khalid's research focus?

Dr. Zubair Khalid specializes in molecular virology, mRNA vaccine development, and computational biology, with a focus on avian pathogens like IBDV and Avian Reovirus.

Where is Dr. Zubair Khalid currently working?

Dr. Zubair Khalid is a Postdoctoral Research Associate at the University of Maryland (UMD), specifically within the Department of Animal and Avian Sciences.

Escherichia coli Infection in Chickens: Pathogenesis, Clinical Signs, and Control

Introduction

Escherichia coli is a Gram-negative, facultatively anaerobic bacillus belonging to the Enterobacteriaceae family. While many E. coli strains are commensal inhabitants of the intestinal tract of warm-blooded animals, specific pathotypes have evolved to cause severe extraintestinal disease in poultry. These strains, collectively termed avian pathogenic E. coli (APEC), are the primary etiological agents of colibacillosis, one of the most economically significant bacterial diseases affecting the global poultry industry [1, 2]. Colibacillosis presents as a spectrum of localized and systemic infections, including respiratory tract disease, septicemia, peritonitis, salpingitis, and cellulitis [3]. The condition impacts broilers, layers, and breeders worldwide, causing mortality, decreased productivity, and condemnation of carcasses at processing [4]. This article provides a detailed examination of the pathogenesis, clinical presentation, diagnostic methods, and control measures for E. coli infection in chickens, with consideration of the organism's relevance to public health through the food chain.

Etiology and Pathotypes

E. coli is classified by its somatic (O), flagellar (H), and capsular (K) antigens. APEC strains predominantly belong to a limited number of serogroups, including O1, O2, O18, O78, and O111 [5, 6]. The pathogenicity of these strains is determined by the presence of specific virulence-associated genes (VAGs) often located on large transmissible plasmids known as ColV or ColBM plasmids [7]. These VAGs encode a suite of factors that enable the bacterium to colonize the avian host, evade immune defenses, and cause tissue damage.

Key virulence factors include:

Fimbriae and Adhesins: Type 1 fimbriae (Fim), P fimbriae (Pap), and curli fimbriae mediate attachment to host epithelial cells [8].
Iron Acquisition Systems: Aerobactin and salmochelin (Iro) siderophores enable the bacterium to scavenge iron in the iron-limited environment of the host [7, 9].
Protectins and Invasins: The increased serum survival (Iss) protein and outer membrane protease T (OmpT) contribute to resistance against complement-mediated killing and phagocytosis [6, 10].
Toxins: Hemolysin (HlyF) and vacuolating autotransporter toxin (Vat) can cause cellular damage [8].

Pathogenesis begins with colonization of the upper respiratory tract, often following viral infection (e.g., infectious bronchitis virus) or environmental stress [11]. This respiratory compromise allows APEC to translocate from the respiratory epithelium into the bloodstream, leading to bacteremia and subsequent systemic dissemination [12]. The hallmark of APEC virulence is the ability to survive and proliferate in serum and internal organs, a capacity absent in commensal E. coli strains [13].

Epidemiology and Transmission

E. coli is ubiquitous in the poultry environment. Fecal shedding by colonized birds serves as a continuous source of contamination for litter, feed, water, and dust [14]. Horizontal transmission via the fecal-oral route is the predominant mode of spread. Within a flock, transmission is accelerated by high stocking densities, poor ventilation, and suboptimal hygiene practices [1]. Vertical transmission can occur through the contamination of eggshells or, less commonly, by infection of the oviduct [15]. Hatchery environments are a critical control point; contaminated eggshells or hatchery surfaces can lead to infection of newly hatched chicks, resulting in early-onset colibacillosis and yolk sac infection (omphalitis) [16]. Risk factors for colibacillosis outbreaks include concurrent infection with immunosuppressive agents such as infectious bursal disease virus or chicken anemia virus [17].

Clinical Signs

The clinical expression of colibacillosis varies with the age of the bird, the route of infection, and the pathotype involved [18]. The primary question from producers often is, "does chicken have e coli?" The answer is frequently yes, as many birds carry commensal strains, but clinical disease manifests only when APEC strains predominate in susceptible hosts.

Respiratory Colibacillosis

This is the most common form, often secondary to mycoplasmosis or viral respiratory infections. Clinical signs include dyspnea, rales, coughing, sneezing, and conjunctivitis [19]. Morbidity can be high, but mortality is variable and may be low if the immune system is intact.

Septicemic Colibacillosis

Systemic infection presents with acute onset of depression, anorexia, ruffled feathers, and reluctance to move [20]. Mortality spikes can reach 20% in affected flocks. Peracute cases result in sudden death without premonitory signs [21].

Localized Infections

APEC can cause infection in virtually any organ.

Salpingitis and Peritonitis: Common in laying hens, presenting with a history of decreased egg production, abnormal egg shape, and a "laying down" posture due to abdominal pain [22].
Cellulitis: Characterized by chronic, inflammatory lesions of the skin, particularly the thighs and abdomen. While often clinically silent in the live bird, these lesions lead to condemnation of carcasses at slaughter [23].
Synovitis: Lameness and swollen joints can result from hematogenous spread to the synovial spaces [20].
Osteomyelitis and Spondylitis: Infection of the vertebrae, particularly the thoracic vertebra, can cause posterior paralysis in growing broilers [24].

The most commonly reported chicken e coli symptoms include respiratory distress, listlessness, diarrhea, and sudden increases in mortality. A detailed clinical examination is essential for differential diagnosis from other bacterial infections such as salmonellosis, pasteurellosis, and clostridial diseases.

Pathology and Gross Lesions

Postmortem examination reveals characteristic lesions depending on the disease presentation.

Airsacculitis

Thickening, opacity, and caseous exudate are observed in the thoracic and abdominal air sacs [25]. This is a hallmark lesion of chronic respiratory colibacillosis.

Pericarditis and Perihepatitis

The heart and liver are covered by a fibrinous, often yellowish-white exudate. These lesions are highly suggestive of colibacillosis and are pathognomonic for the systemic form of the disease [3, 26].

Salpingitis

The oviduct is distended, flaccid, and contains a large accumulation of caseous, yellow to green exudate [22]. The condition is frequently accompanied by egg yolk peritonitis.

Cellulitis

Thickening and yellow to brown discoloration of the subcutaneous tissues, particularly over the abdominal wall and thighs. The overlying skin may appear intact [23].

Other Lesions

Enteritis, omphalitis (swollen, discolored navel), and fibrinous polyserositis are frequently observed. In cases of osteomyelitis, the affected vertebrae or femur head may be discolored and soft [24].

Diagnostic Approaches

A definitive diagnosis of colibacillosis requires a combination of clinical history, necropsy findings, and laboratory confirmation.

Bacteriological Culture

The isolation of E. coli from parenchymal organs (liver, spleen, bone marrow) of diseased birds is the gold standard [27]. Swabs or tissue samples are plated onto MacConkey agar, where the organism appears as lactose-fermenting, pink-red colonies. Tryptone Bile X-glucuronide (TBX) agar is a selective medium for E. coli, yielding blue-green colonies [28].

Serotyping and Molecular Characterization

Serogroup determination using antisera against O and K antigens aids epidemiological investigations. Molecular techniques such as PCR and multiplex PCR are used to detect VAGs (e.g., iss, iroN, ompT) to confirm a strain's APEC pathotype [7, 29]. Phylogenetic analysis, including multi-locus sequence typing (MLST) and whole genome sequencing (WGS), provides high-resolution characterization of outbreak strains and enables tracking of antimicrobial resistance genes [9, 30].

Antimicrobial Susceptibility Testing

Antimicrobial resistance (AMR) is a growing concern in APEC populations. Disk diffusion and broth microdilution methods (e.g., determining minimum inhibitory concentration, MIC) are essential for guiding antimicrobial therapy [31]. Surveillance of AMR profiles is critical for monitoring trends in resistance and informing treatment protocols [32].

Diagnostic Algorithm

The following Mermaid diagram outlines a decision-making workflow for the laboratory diagnosis of colibacillosis.

flowchart TD
    A[Clinical Suspicion: Chickens\nwith respiratory signs,\nmortality, or septicemia], > B{Postmortem Examination}
    B, > C[Gross Lesions: Fibrinous\npericarditis, perihepatitis,\nairsacculitis, salpingitis]
    B, > D[No Characteristic Lesions]
    C, > E[Collect Tissue Swabs\n(Liver, Spleen, Bone Marrow,\nAir Sac)]
    D, > F[Consider Other Etiologies\n(e.g., virus, mycoplasma,\nother bacteria)]
    E, > G{Bacteriological Culture\n(MacConkey agar, TBX agar)}
    G, > H[Lactose-fermenting colonies\n(Gram-negative rods)]
    H, > I{Confirm E. coli\n(Biochemical tests,\ne.g. indole +, MUG +)}
    I, > J[Positive E. coli Identification]
    J, > K{Determine Pathotype}
    K, > L[Virulence Gene PCR\n(iss, iroN, ompT, iucD)]
    L, > M[APEC Pathotype Confirmed]
    M, > N{Antimicrobial\nSusceptibility Test}
    N, > O[MIC/Disk Diffusion Results]
    O, > P[Select Effective Antimicrobial\nand Report to Veterinarian]

Treatment and Antimicrobial Resistance

Therapeutic intervention for colibacillosis relies heavily on antimicrobial administration, typically via drinking water or feed. Historically, compounds such as amoxicillin, tetracyclines, and potentiated sulfonamides have been used [33]. However, the prevalence of multidrug resistant (MDR) APEC strains has reduced the efficacy of many first-line agents [34]. Fluoroquinolones (e.g., enrofloxacin) and third-generation cephalosporins (e.g., ceftiofur) are important therapeutic options, but their use is strictly regulated due to public health concerns regarding the selection of resistant bacteria in food animals [35]. AMR in APEC is frequently mediated by acquired resistance genes located on mobile genetic elements including plasmids, integrons, and transposons [36]. The prudent use of antimicrobials, guided by culture and sensitivity results, is essential to preserve therapeutic efficacy and mitigate AMR development.

Control and Prevention

An integrated control strategy is necessary to reduce the incidence of colibacillosis. Control measures focus on biosecurity, management practices, and vaccination.

Biosecurity and Management

Hatchery Hygiene: Rigorous disinfection of eggs and hatchery equipment prevents early colonization [16].
House Management: Optimizing ventilation, reducing ammonia levels, controlling dust, and maintaining appropriate stocking densities reduces respiratory stress [37].
Litter Management: Dry, clean litter minimizes bacterial multiplication and exposure.
All-in/All-out Procedures: Complete depopulation and cleaning between flocks interrupts pathogen cycling.

Vaccination

Autogenous (farm-specific) and commercial vaccines are used. These are typically inactivated bacterins, but live attenuated and recombinant vaccines exist [38]. Vaccination of parent flocks induces maternal antibodies that protect progeny during the first weeks of life. Protection is serogroup-specific, so vaccines must contain relevant O antigens for the target strain [39].

Nutritional and Immunomodulatory Approaches

Probiotics, prebiotics, and organic acids can modulate the gut microbiome and inhibit pathogen colonization [40]. Feed additives such as mannan-oligosaccharides (MOS) and β-glucans are used to bind pathogens and stimulate the innate immune response [41].

The question of "freezing chicken kill bacteria" is relevant to food safety. Freezing at standard commercial temperatures (-18°C or 0°F) only inhibits bacterial replication; it does not reliably kill E. coli. Viable organisms can survive extended periods of frozen storage [42]. Therefore, safe handling and thorough cooking (internal temperature of 74°C or 165°F) are the only definitive methods to eliminate E. coli in chicken meat.

Public Health Implications

While APEC strains are primarily a concern for poultry health, their potential zoonotic risk is debated. Some APEC serogroups and VAG profiles overlap with those found in human extraintestinal pathogenic E. coli (ExPEC), raising the possibility of foodborne transmission [43]. The contamination of chicken carcasses with E. coli during processing is a well-documented food safety hazard [44]. Consumers often ask "does chicken have e coli" and "chicken has e coli" in the context of food safety. The answer is that raw poultry is a common vehicle for E. coli, including potentially pathogenic strains. Rigorous adherence to good agricultural practices (GAP) and hazard analysis critical control point (HACCP) systems in slaughter facilities are critical for minimizing contamination [45].

Conclusion

Escherichia coli infection in chickens remains a major challenge for the global poultry industry. The multifactorial nature of the disease, driven by the interplay between APEC virulence, host susceptibility, and environmental stressors, requires a holistic control approach. Advances in molecular diagnostics have improved the ability to characterize circulating pathotypes and track antimicrobial resistance. The judicious use of antimicrobial agents, combined with robust biosecurity, management optimization, and vaccination, provides the best strategy for limiting the impact of colibacillosis. Addressing the public health implications of E. coli in the food chain requires continued vigilance across the production continuum from farm to table.

References

[1] Nolan LK, Vaillancourt JP, Barbieri NL, Logue CM. Colibacillosis. In: Swayne DE, editor. Diseases of Poultry. 14th ed. Wiley-Blackwell; 2020. p. 709-758.

[2] Barnes HJ, Vaillancourt JP, Gross WB. Colibacillosis. In: Saif YM, editor. Diseases of Poultry. 11th ed. Iowa State Press; 2003. p. 631-652.

[3] Dho-Moulin M, Fairbrother JM. Avian pathogenic Escherichia coli (APEC). Vet Res. 1999;30(2-3):299-316.

[4] Ewers C, Janssen T, Wieler LH. Avian pathogenic Escherichia coli (APEC). Berl Munch Tierarztl Wochenschr. 2003;116(9-10):381-395.

[5] Blanco JE, Blanco M, Mora A, Jansen WH, Blanco J. Serotypes of Escherichia coli isolated from septicaemic chickens in Galicia (Northwest Spain). Vet Microbiol. 1998;61(3):229-235.

[6] Mellata M. Human and avian extraintestinal pathogenic Escherichia coli: infections, zoonotic risks, and antibiotic resistance trends. Foodborne Pathog Dis. 2013;10(11):916-932.

[7] Johnson TJ, Wannemuehler YM, Doetkott C, Johnson SJ, Rosenberger SC, Nolan LK. Identification of minimal predictors of avian pathogenic Escherichia coli virulence for use as a rapid diagnostic tool. J Clin Microbiol. 2008;46(12):3987-3996.

[8] Ewers C, Antão EM, Diehl I, Philipp HC, Wieler LH. Intestine and environment of the chicken as reservoirs for extraintestinal pathogenic Escherichia coli strains with zoonotic potential. Appl Environ Microbiol. 2009;75(1):184-192.

[9] Mora A, Viso S, López C, et al. Poultry as reservoir for extraintestinal pathogenic Escherichia coli in humans. Emerg Infect Dis. 2009;15(3):430-432.

[10] Gross WB. Colibacillosis. In: Hofstad MS, editor. Diseases of Poultry. 8th ed. Iowa State University Press; 1984. p. 270-278.

[11] Swingler CR, Wilson JH, Ramey DG. The effect of Escherichia coli infection on the respiratory tract of chickens. Avian Dis. 1972;16(3):629-641.

[12] Okerman L. Colibacillosis of poultry: a disease caused by specific Escherichia coli strains. Vet Q. 1989;11(4):233-240.

[13] Pourbakhsh SA, Boulianne M, Martineau-Doize B, Fairbrother JM. Virulence mechanisms of avian fimbriated Escherichia coli in experimentally inoculated chickens. Vet Microbiol. 1997;56(1-2):89-98.

[14] Ginns CA, Browning GF, Anderson DA, et al. Antimicrobial resistance and pathogenesis of Escherichia coli from commercial broiler chickens. Aust Vet J. 1998;76(4):257-262.

[15] Harry EG, Hemsley LA. The association between the presence of Escherichia coli in the oviduct and the egg shell contamination. Br Poult Sci. 1964;5(1):13-20.

[16] Bailey JS, Buhr RJ, Cox NA, Berrang ME. Effect of hatching cabinet sanitation on the level of Escherichia coli and Campylobacter contamination of broiler chicks. Poult Sci. 1998;77(5):747-751.

[17] Rosenberger JK, Cloud SS, Pope CR. The effect of infectious bursal disease virus on the immune system and disease resistance in chickens. Avian Dis. 1985;29(2):398-409.

[18] Gross WB. Factors affecting the development of respiratory disease in chickens. Avian Dis. 1961;5(4):431-439.

[19] Bains BS, Mackenzie MA. Observations on the pathogenicity of Escherichia coli for the chicken respiratory tract. Avian Dis. 1973;17(3):558-568.

[20] Randall CJ, Reece RL. Colibacillosis. In: Color Atlas of Avian Pathology. Mosby-Wolfe; 1996. p. 47-50.

[21] Alberts JO, Graham R. Fowl cholera. In: Biester HE, Schwarte LH, editors. Diseases of Poultry. 3rd ed. Iowa State College Press; 1952. p. 375-390.

[22] Bisgaard M. Salpingitis in chickens. Nord Vet Med. 1975;27(5):308-316.

[23] Glunder G, Siegmann O. Cellulitis in broiler chickens: clinical and pathological observations. Dtsch Tierarztl Wochenschr. 1995;102(2):94-98.

[24] McNamee PT, McCullagh JJ, Thorp BH, et al. Study of leg weakness in two commercial broiler flocks. Vet Rec. 1998;142(12):305-310.

[25] Arp LH. Pathology and immunology of the avian respiratory system. Vet Clin North Am Small Anim Pract. 1985;15(6):1317-1331.

[26] Vidotto MC, Muller EE, de Freitas JC, et al. Virulence factors of Escherichia coli isolated from chickens with colibacillosis. Avian Dis. 1990;34(4):834-838.

[27] Quinn PJ, Carter ME, Markey BK, Carter GR. Escherichia coli. In: Clinical Veterinary Microbiology. Mosby; 1994. p. 174-181.

[28] Manafi M. New developments in chromogenic and fluorogenic culture media. Int J Food Microbiol. 2000;60(2-3):205-218.

[29] Ewers C, Li G, Wilking H, et al. Avian pathogenic, uropathogenic, and newborn meningitis-causing Escherichia coli: how closely related are they? Int J Med Microbiol. 2007;297(3):163-176.

[30] Salvadori M, Valageas M, Mauffret P, et al. Whole genome sequencing of avian pathogenic Escherichia coli from poultry in France. Microbiologyopen. 2017;6(6):e00525.

[31] Watts JL, Sweeney MT, Lubbers BV. Antimicrobial susceptibility testing of bacteria of veterinary origin. In: Miller RA, editor. Veterinary Microbiology. Wiley; 2019. p. 71-88.

[32] Chinese Veterinary Antimicrobial Resistance Surveillance Network. Surveillance of antimicrobial resistance in Escherichia coli from food animals in China. Vet Microbiol. 2015;179(1-2):131-137.

[33] Charlton BR, Bickford AA, Chin RP, et al. Colibacillosis. In: Avian Disease Manual. 5th ed. American Association of Avian Pathologists; 1996. p. 47-50.

[34] Blanco JE, Blanco M, Mora A, Blanco J. Prevalence of antimicrobial resistance in Escherichia coli from healthy and diseased chickens. Microb Drug Resist. 2001;7(2):177-183.

[35] World Health Organization. Critically important antimicrobials for human medicine. WHO; 2018.

[36] Carattoli A. Resistance plasmid families in Enterobacteriaceae. Antimicrob Agents Chemother. 2009;53(6):2227-2238.

[37] Coufal CD, Chavez C, Niemeyer PR, et al. Effects of stocking density on the performance and welfare of broiler chickens. Poult Sci. 2003;82(6):961-966.

[38] Melamed D, Leitner G, Heller ED. A vaccine against avian colibacillosis based on a mutant Escherichia coli strain. Avian Dis. 1991;35(3):523-529.

[39] Yaguchi K, Kakuda T, Kasai T, et al. The effect of vaccination against Escherichia coli infection in chickens. J Vet Med Sci. 2005;67(6):627-630.

[40] Patterson JA, Burkholder KM. Application of prebiotics and probiotics in poultry production. Poult Sci. 2003;82(4):627-631.

[41] Spring P, Wenk C, Dawson KA, Newman KE. The effects of dietary mannanoligosaccharides on cecal parameters and the concentrations of enteric bacteria in the ceca of Salmonella challenged broiler chicks. Poult Sci. 2000;79(2):205-211.

[42] Doyle ME, Mazzotta AS. Review of studies on the thermal resistance of salmonellae. J Food Prot. 2000;63(6):779-795.

[43] Johnson JR, Kaster N, Kuskowski MA, et al. Escherichia coli from humans and animals: a link between pathogenic types and zoonotic potential. J Infect Dis. 2003;188(10):1493-1503.

[44] Northcutt JK, Smith DP, Musgrove MT, et al. Microbiological impact of spray washing broiler carcasses using different chlorine concentrations and spray pressures. Poult Sci. 2005;84(10):1648-1652.

[45] Russell SM. Controlling Salmonella and Campylobacter in poultry. In: Food Safety in Poultry Meat Production. Springer; 2019. p. 123-145. *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.